Cingulate Inc. (CING): EPS (Basic)
-$4.44
Year ended 2025-12-31
| Period ended | EPS (Basic) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$4.44 | n/m | 2026-03-18, From 2025-01-01 |
| 2024-12-31 | -$10.86 | n/c | 2026-03-18, From 2024-01-01 |
| 2023-12-31 | -$311.99 | n/c | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | -$29.35 | n/m | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | -$2.79 | n/a | 2023-03-10, From 2021-01-01 |
EPS (Basic) at similar companies
| Company | Year ended | EPS (Basic) | Change YoY |
|---|---|---|---|
| Cingulate Inc. (CING) | 2025-12-31 | -$4.44 | n/m |
| Cellectar Biosciences, Inc. (CLRB) | 2025-12-31 | -$8.35 | n/m |
| Synlogic, Inc. (SYBX) | 2025-12-31 | -$0.08 | n/m |
| Reviva Pharmaceuticals Holdings, Inc. (RVPH) | 2025-12-31 | -$5.48 | n/m |
| Aprea Therapeutics, Inc. (APRE) | 2025-12-31 | -$1.93 | n/m |
| Biovie Inc. (BIVI) | 2026-06-30 | -$3.05 | n/m |
| Anixa Biosciences Inc (ANIX) | 2025-10-31 | -$0.34 | n/m |
| Exicure, Inc. (XCUR) | 2025-12-31 | -$0.79 | n/m |
| Actuate Therapeutics, Inc. (ACTU) | 2025-12-31 | -$1.06 | n/m |
Compare CING, CLRB, SYBX, RVPH side by side · Screen every company in Pharmaceutical Preparations ↗